4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-044166
EVP, Research & CSO sold 1,375 shares at $46.63 ($64,116)
- EVP, Research & CSO acquired 1,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-06-29 | Option exercise | +1,375 | $1.53 | $2,104 | 101,075 | D |
| Virgin Herbert EVP, Research & CSO | 2021-06-29 | Sale | −1,375 | $46.63 | $64,116 | 99,700 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2021-06-29 | Option exercise · Stock Option (Right to Buy) | −1,375 | 289,380 | D | ||
| Open-market sales · 1,375 sh · avg $46.63 · $64,116 | |||||||
Loading xslF345X03/doc4.xml…